Stay updated with breaking news from 03236m10. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Endurance Wealth Management Inc. raised its position in Amyris, Inc. (NASDAQ:AMRS – Free Report) by 87.7% during the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 37,450 shares of the biotechnology company’s stock after acquiring an additional 17,500 shares during the period. Endurance Wealth Management Inc.’s holdings in […]
Amyris, Inc. (NASDAQ:AMRS – Get Rating) has been given an average rating of “Hold” by the seven brokerages that are presently covering the firm, Marketbeat.com reports. Six equities research analysts have rated the stock with a hold recommendation and one has issued a buy recommendation on the company. The average 12 month target price among […]
Amyris, Inc. (NASDAQ:AMRS – Get Rating) was the recipient of some unusual options trading activity on Thursday. Investors bought 9,623 put options on the stock. This is an increase of 48% compared to the average daily volume of 6,507 put options. Insider Buying and Selling at Amyris In other Amyris news, COO Eduardo Alvarez sold […]
Amyris (NASDAQ:AMRS – Get Rating) was downgraded by research analysts at Jefferies Financial Group from a “buy” rating to a “hold” rating in a report issued on Thursday, The Fly reports. They currently have a $0.65 price target on the biotechnology company’s stock, down from their previous price target of $3.10. Jefferies Financial Group’s price […]
TD Cowen lowered shares of Amyris (NASDAQ:AMRS – Get Rating) from an outperform rating to a market perform rating in a report released on Wednesday morning, Marketbeat.com reports. TD Cowen currently has $1.25 target price on the biotechnology company’s stock, down from their previous target price of $4.00. Several other research analysts have also commented […]